ACTRN12623000931673招募中Unknown
Evaluating the safety and efficacy of sacituzumab govitecan (SG) in patients with previously treated unresectable locally advanced or metastatic triple negative breast cancer (advanced TNB) through creation of a patient registry using secondary data.
Walter and Eliza Hall Institute0 个研究点目标入组 200 人开始时间: 2023年8月29日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.Patients with metastatic, or inoperable, locally advanced TNBC (either relapsed or de novo metastatic)
- •2.Patients who started SG during the patient identification period according to the locally approved indication:
- •Treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) who have received at least two prior systemic therapies, including at least one prior therapy for locally advanced or metastatic disease”
排除标准
- •1.Patients participating in any interventional clinical trials during SG treatment
- •2.History of SG use prior to first administration for advanced TNBC
研究者
相似试验
招募中
2 期
To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma.Ewing's sarcoma2024-514441-11-00Instytut Matki I Dziecka24
招募中
1 期
To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma.Ewing's sarcomaCTIS2024-514441-11-00Instytut Matki I Dziecka24
招募中
4 期
imotuzumab in tumors of head and neck .Phase IVTumors of head and neck in advanced stages.RPCEC00000145Center of Molecular Immunology (CIM)404
招募中
2 期
Study of the efficacy and safety of gemtuzumab ozogamicin treatment intervention with measurable residual disease as an index for AYA/adult acute myeloid leukemia with t(8;21) and inv(16)JPRN-jRCTs041200063Toshihiro Miyamoto117
招募中
2 期
Evaluation the Efficacy and Safety of Tocilizumab in COVID-19COVID-19 pneumonia.Confirmed diagnosis of COVID-19RA01.0IRCT20151227025726N13Shahid Beheshti University of Medical Sciences40